Moving pathogen genomics out of the lab and into the clinic: what will it take?

Abstract:

:Pathogen genomic analysis is a potentially transformative new approach to the clinical and public-health management of infectious diseases. Health systems investing in this technology will need to build infrastructure and develop policies that ensure genomic information can be generated, shared and acted upon in a timely manner.

journal_name

Genome Med

journal_title

Genome medicine

authors

Luheshi LM,Raza S,Peacock SJ

doi

10.1186/s13073-015-0254-z

subject

Has Abstract

pub_date

2015-12-30 00:00:00

pages

132

issue

1

issn

1756-994X

pii

10.1186/s13073-015-0254-z

journal_volume

7

pub_type

杂志文章
  • Erratum to: a SNP profiling panel for sample tracking in whole-exome sequencing studies.

    abstract::This is an Erratum to Genome Medicine 2013, 5:89, highlighting an error in Table 1 of the original article. Please see related article: http://genomemedicine.com/content/5/9/89.[This corrects the article DOI: 10.1186/gm492.]. ...

    journal_title:Genome medicine

    pub_type: 已发布勘误

    doi:10.1186/s13073-015-0163-1

    authors: Pengelly RJ,Gibson J,Andreoletti G,Collins A,Mattocks CJ,Ennis S

    更新日期:2015-05-07 00:00:00

  • The pan-cancer landscape of prognostic germline variants in 10,582 patients.

    abstract:BACKGROUND:While clinical factors such as age, grade, stage, and histological subtype provide physicians with information about patient prognosis, genomic data can further improve these predictions. Previous studies have shown that germline variants in known cancer driver genes are predictive of patient outcome, but no...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-020-0718-7

    authors: Chatrath A,Przanowska R,Kiran S,Su Z,Saha S,Wilson B,Tsunematsu T,Ahn JH,Lee KY,Paulsen T,Sobierajska E,Kiran M,Tang X,Li T,Kumar P,Ratan A,Dutta A

    更新日期:2020-02-17 00:00:00

  • Consensus: a framework for evaluation of uncertain gene variants in laboratory test reporting.

    abstract::Accurate interpretation of gene testing is a key component in customizing patient therapy. Where confirming evidence for a gene variant is lacking, computational prediction may be employed. A standardized framework, however, does not yet exist for quantitative evaluation of disease association for uncertain or novel g...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm347

    authors: Crockett DK,Ridge PG,Wilson AR,Lyon E,Williams MS,Narus SP,Facelli JC,Mitchell JA

    更新日期:2012-05-28 00:00:00

  • Digital transcriptome profiling of normal and glioblastoma-derived neural stem cells identifies genes associated with patient survival.

    abstract:BACKGROUND:Glioblastoma multiforme, the most common type of primary brain tumor in adults, is driven by cells with neural stem (NS) cell characteristics. Using derivation methods developed for NS cells, it is possible to expand tumorigenic stem cells continuously in vitro. Although these glioblastoma-derived neural ste...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm377

    authors: Engström PG,Tommei D,Stricker SH,Ender C,Pollard SM,Bertone P

    更新日期:2012-10-09 00:00:00

  • A comparison of epigenetic mitotic-like clocks for cancer risk prediction.

    abstract:BACKGROUND:DNA methylation changes that accrue in the stem cell pool of an adult tissue in line with the cumulative number of cell divisions may contribute to the observed variation in cancer risk among tissues and individuals. Thus, the construction of epigenetic "mitotic" clocks that can measure the lifetime number o...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-020-00752-3

    authors: Teschendorff AE

    更新日期:2020-06-24 00:00:00

  • Microbiome mediation of infections in the cancer setting.

    abstract::Infections encountered in the cancer setting may arise from intensive cancer treatments or may result from the cancer itself, leading to risk of infections through immune compromise, disruption of anatomic barriers, and exposure to nosocomial (hospital-acquired) pathogens. Consequently, cancer-related infections are u...

    journal_title:Genome medicine

    pub_type: 杂志文章,评审

    doi:10.1186/s13073-016-0306-z

    authors: Taur Y,Pamer EG

    更新日期:2016-04-18 00:00:00

  • DNA methylation signature in blood mirrors successful weight-loss during lifestyle interventions: the CENTRAL trial.

    abstract:BACKGROUND:One of the major challenges in obesity treatment is to explain the high variability in the individual's response to specific dietary and physical activity interventions. With this study, we tested the hypothesis that specific DNA methylation changes reflect individual responsiveness to lifestyle intervention...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-020-00794-7

    authors: Keller M,Yaskolka Meir A,Bernhart SH,Gepner Y,Shelef I,Schwarzfuchs D,Tsaban G,Zelicha H,Hopp L,Müller L,Rohde K,Böttcher Y,Stadler PF,Stumvoll M,Blüher M,Kovacs P,Shai I

    更新日期:2020-11-16 00:00:00

  • Mining the literature: new methods to exploit keyword profiles.

    abstract:UNLABELLED:Bibliographic records in the PubMed database of biomedical literature are annotated with Medical Subject Headings (MeSH) by curators, which summarize the content of the articles. Two recent publications explain how to generate profiles of MeSH terms for a set of bibliographic records and to use them to defin...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm382

    authors: Andrade-Navarro MA

    更新日期:2012-10-30 00:00:00

  • Integrative analysis of DNA methylation and gene expression reveals hepatocellular carcinoma-specific diagnostic biomarkers.

    abstract:BACKGROUND:Hepatocellular carcinoma (HCC) is the one of the most common cancers and lethal diseases in the world. DNA methylation alteration is frequently observed in HCC and may play important roles in carcinogenesis and diagnosis. METHODS:Using the TCGA HCC dataset, we classified HCC patients into different methylat...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-018-0548-z

    authors: Cheng J,Wei D,Ji Y,Chen L,Yang L,Li G,Wu L,Hou T,Xie L,Ding G,Li H,Li Y

    更新日期:2018-05-30 00:00:00

  • Prenatal diagnosis of fetal aneuploidies: post-genomic developments.

    abstract::Prenatal diagnosis of fetal aneuploidies and chromosomal anomalies is likely to undergo a profound change in the near future. On the one hand this is mediated by new technical developments, such as chromosomal microarrays, which allow a much more precise delineation of minute sub-microscopic chromosomal aberrancies th...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm171

    authors: Hahn S,Jackson LG,Zimmermann BG

    更新日期:2010-08-05 00:00:00

  • Precision cancer mouse models through genome editing with CRISPR-Cas9.

    abstract::The cancer genome is highly complex, with hundreds of point mutations, translocations, and chromosome gains and losses per tumor. To understand the effects of these alterations, precise models are needed. Traditional approaches to the construction of mouse models are time-consuming and laborious, requiring manipulatio...

    journal_title:Genome medicine

    pub_type: 杂志文章,评审

    doi:10.1186/s13073-015-0178-7

    authors: Mou H,Kennedy Z,Anderson DG,Yin H,Xue W

    更新日期:2015-06-09 00:00:00

  • Using inactivating mutations to provide insight into drug action.

    abstract::The role of ezetimibe in lowering plasma cholesterol has been established; however, controversy remains about its clinical benefit. A recent study utilizes naturally occurring genetic variation within the NPC1-like 1 gene (NPC1L1) to demonstrate the potential for pharmacologic inhibition of the protein to reduce the r...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-015-0130-x

    authors: Corbin LJ,Timpson NJ

    更新日期:2015-01-28 00:00:00

  • Novel insights into the HLA class I immunopeptidome and T-cell immunosurveillance.

    abstract::Advances in mass spectrometry have allowed the high-throughput quantitative identification of human leukocyte antigen (HLA) class I ligands, and recent studies have reported on the breadth and diversity of the HLA class I immunopeptidome. These findings have far-reaching implications for immunosurveillance by T cells ...

    journal_title:Genome medicine

    pub_type: 社论,评审

    doi:10.1186/s13073-017-0439-8

    authors: Melief CJM,Kessler JH

    更新日期:2017-05-24 00:00:00

  • DNA methylation-based chromatin compartments and ChIP-seq profiles reveal transcriptional drivers of prostate carcinogenesis.

    abstract:BACKGROUND:Profiles of DNA methylation of many tissues relevant in human disease have been obtained from microarrays and are publicly available. These can be used to generate maps of chromatin compartmentalization, demarcating open and closed chromatin across the genome. Additionally, large sets of genome-wide transcri...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-017-0443-z

    authors: Simmonds P,Loomis E,Curry E

    更新日期:2017-06-07 00:00:00

  • Epigenetics of renal cell carcinoma: the path towards new diagnostics and therapeutics.

    abstract::Aberrant DNA methylation, in particular promoter hypermethylation and transcriptional silencing of tumor suppressor genes, has an important role in the development of many human cancers, including renal cell carcinoma (RCC). Indeed, apart from mutations in the well studied von Hippel-Lindau gene (VHL), the mutation fr...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm180

    authors: Morris MR,Maher ER

    更新日期:2010-09-03 00:00:00

  • Imiquimod has strain-dependent effects in mice and does not uniquely model human psoriasis.

    abstract:BACKGROUND:Imiquimod (IMQ) produces a cutaneous phenotype in mice frequently studied as an acute model of human psoriasis. Whether this phenotype depends on strain or sex has never been systematically investigated on a large scale. Such effects, however, could lead to conflicts among studies, while further impacting st...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-017-0415-3

    authors: Swindell WR,Michaels KA,Sutter AJ,Diaconu D,Fritz Y,Xing X,Sarkar MK,Liang Y,Tsoi A,Gudjonsson JE,Ward NL

    更新日期:2017-03-09 00:00:00

  • Text-mining clinically relevant cancer biomarkers for curation into the CIViC database.

    abstract:BACKGROUND:Precision oncology involves analysis of individual cancer samples to understand the genes and pathways involved in the development and progression of a cancer. To improve patient care, knowledge of diagnostic, prognostic, predisposing, and drug response markers is essential. Several knowledgebases have been ...

    journal_title:Genome medicine

    pub_type: 杂志文章,meta分析

    doi:10.1186/s13073-019-0686-y

    authors: Lever J,Jones MR,Danos AM,Krysiak K,Bonakdar M,Grewal JK,Culibrk L,Griffith OL,Griffith M,Jones SJM

    更新日期:2019-12-03 00:00:00

  • Bridging the gap between systems biology and medicine.

    abstract::Systems biology has matured considerably as a discipline over the last decade, yet some of the key challenges separating current research efforts in systems biology and clinically useful results are only now becoming apparent. As these gaps are better defined, the new discipline of systems medicine is emerging as a tr...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm88

    authors: Clermont G,Auffray C,Moreau Y,Rocke DM,Dalevi D,Dubhashi D,Marshall DR,Raasch P,Dehne F,Provero P,Tegner J,Aronow BJ,Langston MA,Benson M

    更新日期:2009-09-29 00:00:00

  • Cancer detection and biopsy classification using concurrent histopathological and metabolomic analysis of core biopsies.

    abstract:BACKGROUND:Metabolomics, the non-targeted interrogation of small molecules in a biological sample, is an ideal technology for identifying diagnostic biomarkers. Current tissue extraction protocols involve sample destruction, precluding additional uses of the tissue. This is particularly problematic for high value sampl...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm332

    authors: Brown MV,McDunn JE,Gunst PR,Smith EM,Milburn MV,Troyer DA,Lawton KA

    更新日期:2012-04-30 00:00:00

  • Genomic variants associated with primary biliary cirrhosis.

    abstract::Primary biliary cirrhosis (PBC) is an autoimmune hepatobiliary disease characterized by immune-mediated injury of small and medium-sized bile ducts, eventually leading to liver cirrhosis. Several studies have addressed PBC immunopathology, and the data support an immune activation leading to autoantibodies and autorea...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm126

    authors: Selmi C,Torok NJ,Affronti A,Gershwin ME

    更新日期:2010-01-26 00:00:00

  • Pharmacogenomics of adverse drug reactions.

    abstract::Considerable progress has been made in identifying genetic risk factors for idiosyncratic adverse drug reactions in the past 30 years. These reactions can affect various tissues and organs, including liver, skin, muscle and heart, in a drug-dependent manner. Using both candidate gene and genome-wide association studie...

    journal_title:Genome medicine

    pub_type: 杂志文章,评审

    doi:10.1186/gm409

    authors: Daly AK

    更新日期:2013-01-29 00:00:00

  • High-dimensional assessment of B-cell responses to quadrivalent meningococcal conjugate and plain polysaccharide vaccine.

    abstract:BACKGROUND:Neisseria meningitidis is a globally important cause of meningitis and septicaemia. Twelve capsular groups of meningococci are known, and quadrivalent vaccines against four of these (A, C, W and Y) are available as plain-polysaccharide and protein-polysaccharide conjugate vaccines. Here we apply contemporary...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-017-0400-x

    authors: O'Connor D,Clutterbuck EA,Thompson AJ,Snape MD,Ramasamy MN,Kelly DF,Pollard AJ

    更新日期:2017-01-30 00:00:00

  • Exploiting the noise: improving biomarkers with ensembles of data analysis methodologies.

    abstract:BACKGROUND:The advent of personalized medicine requires robust, reproducible biomarkers that indicate which treatment will maximize therapeutic benefit while minimizing side effects and costs. Numerous molecular signatures have been developed over the past decade to fill this need, but their validation and up-take into...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm385

    authors: Starmans MH,Pintilie M,John T,Der SD,Shepherd FA,Jurisica I,Lambin P,Tsao MS,Boutros PC

    更新日期:2012-11-12 00:00:00

  • An ethics safe harbor for international genomics research?

    abstract:BACKGROUND:Genomics research is becoming increasingly globally connected and collaborative, contesting traditional ethical and legal boundaries between global and local research practice. As well, global data-driven genomics research holds great promise for health discoveries. Yet, paradoxically, current research ethic...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm503

    authors: Dove ES,Knoppers BM,Zawati MH

    更新日期:2013-11-22 00:00:00

  • Moderate- to low-risk variant alleles of cutaneous malignancies and nevi: lessons from genome-wide association studies.

    abstract::Cutaneous malignancies, especially malignant melanoma, exhibit great genetic heterogeneity. As a result, some individuals and families have particularly increased risk due to genetic predisposition to the disease. The susceptibility alleles range from rarely occurring, heritable, high-risk variants to ubiquitously occ...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm95

    authors: Udayakumar D,Tsao H

    更新日期:2009-10-27 00:00:00

  • Therapy-induced stress response is associated with downregulation of pre-mRNA splicing in cancer cells.

    abstract:BACKGROUND:Abnormal pre-mRNA splicing regulation is common in cancer, but the effects of chemotherapy on this process remain unclear. METHODS:To evaluate the effect of chemotherapy on slicing regulation, we performed meta-analyses of previously published transcriptomic, proteomic, phosphoproteomic, and secretome datas...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-018-0557-y

    authors: Anufrieva KS,Shender VО,Arapidi GP,Pavlyukov MS,Shakhparonov MI,Shnaider PV,Butenko IO,Lagarkova MA,Govorun VM

    更新日期:2018-06-27 00:00:00

  • MeCP2 mutations: progress towards understanding and treating Rett syndrome.

    abstract::Rett syndrome is a profound neurological disorder caused by mutations in the MECP2 gene, but preclinical research has indicated that it is potentially treatable. Progress towards this goal depends on the development of increasingly relevant model systems and on our improving knowledge of MeCP2 function in the brain. ...

    journal_title:Genome medicine

    pub_type: 信件,评审

    doi:10.1186/s13073-017-0411-7

    authors: Shah RR,Bird AP

    更新日期:2017-02-17 00:00:00

  • The prognostic potential of alternative transcript isoforms across human tumors.

    abstract:BACKGROUND:Phenotypic changes during cancer progression are associated with alterations in gene expression, which can be exploited to build molecular signatures for tumor stage identification and prognosis. However, it is not yet known whether the relative abundance of transcript isoforms may be informative for clinica...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-016-0339-3

    authors: Trincado JL,Sebestyén E,Pagés A,Eyras E

    更新日期:2016-08-17 00:00:00

  • From small studies to precision medicine: prioritizing candidate biomarkers.

    abstract::There are still many open questions in data-analytic research pertaining to biomarker development in the era of personalized/precision medicine and big data. Among them is the question of what constitutes best practice for the extraction of prioritized lists of candidate biomarkers from smaller studies that are 'hypot...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm507

    authors: Gaile DP,Miecznikowski JC

    更新日期:2013-11-29 00:00:00

  • Best practices for bioinformatic characterization of neoantigens for clinical utility.

    abstract::Neoantigens are newly formed peptides created from somatic mutations that are capable of inducing tumor-specific T cell recognition. Recently, researchers and clinicians have leveraged next generation sequencing technologies to identify neoantigens and to create personalized immunotherapies for cancer treatment. To cr...

    journal_title:Genome medicine

    pub_type: 杂志文章,评审

    doi:10.1186/s13073-019-0666-2

    authors: Richters MM,Xia H,Campbell KM,Gillanders WE,Griffith OL,Griffith M

    更新日期:2019-08-28 00:00:00